Could The US FDA Set Clinical Trial Diversity Minimums?

Cancer clinical trial diversity panel discussion
FDA, industry and patient advocates discussed clinical trial diversity issues during a 4 May Cancer Moonshot community conversation. • Source: screenshot
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Clinical Trials

More from R&D